Approval · Notice of Compliance 34396 · 2024
PLAN B: Notice of Compliance 34396
Issued November 15, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34396
- Date
- November 15, 2024
- Company
- Foundation Consumer Healthcare, LlcPittsburgh, Pennsylvania, United States
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety and efficacy information. Product Monograph reformatted to the Master Template. Update to package insert. Update to package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLAN B | Not yet assigned | — |
Medicinal ingredients
- LEVONORGESTREL 1.5 MG per TAB